Author:
Pellizzon Antonio Cássio Assis
Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. Smith RA, Cokkinides V, von Eschenbach AC, et al.: American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2002, 52:8–22.
2. Ministério da Saúde, Secretaria Nacional de Assistência à Saúde, Instituto Nacional do Câncer, Brasil: Estimativa de incidência e mortalidade por câncer no Brasil 2006. Rio de Janeiro: Instituto Nacional do Câncer; 2006:36.
3. Galalae RM, Martinez A, Mate T, et al.: Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004, 58:1048–1055.
4. Pellizzon AC, Salvajoli JV, Maia MA, et al.: Late urinary morbidity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer. J Urol 2004, 171:1105–1108.
5. Vicini FA, Vargas C, Edmundson G, et al.: The role of high-dose rate brachytherapy in locally advanced prostate cancer. Semin Radiat Oncol 2003, 13:98–108.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献